Fortis Malar Hospitals Ltd vs Tarsons Products Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Fortis Malar Hospitals Ltd is ₹ 40.21 as of 23 Oct 15:30 . The P/E Ratio of Fortis Malar Hospitals Ltd changed from 1.9 on March 2024 to 18.9 on March 2026 . This represents a CAGR of 115.06% over 3 yearsThe P/E Ratio of Tarsons Products Ltd changed from 37.2 on March 2022 to 62 on March 2026 . This represents a CAGR of 10.76% over 5 years The Market Cap of Fortis Malar Hospitals Ltd changed from ₹ 103.92 crore on March 2021 to ₹ 78.13 crore on March 2026 . This represents a CAGR of -4.64% over 6 yearsThe Market Cap of Tarsons Products Ltd changed from ₹ 3746 crore on March 2022 to ₹ 887.21 crore on March 2026 . This represents a CAGR of -25.03% over 5 years The revenue of Fortis Malar Hospitals Ltd for the Jun '26 is ₹ 0.54 crore as compare to the Mar '26 revenue of ₹ 0.66 crore. This represent the decline of -18.18% The revenue of Tarsons Products Ltd for the Jun '26 is ₹ 116.22 crore as compare to the Mar '26 revenue of ₹ 127.76 crore. This represent the decline of -9.03% The ebitda of Fortis Malar Hospitals Ltd for the Jun '26 is ₹ 0.2 crore as compare to the Mar '26 ebitda of ₹ 0.11 crore. This represent the growth of 81.82% The ebitda of Tarsons Products Ltd for the Jun '26 is ₹ 31.96 crore as compare to the Mar '26 ebitda of ₹ 41.1 crore. This represent the decline of -22.24% The net profit of Fortis Malar Hospitals Ltd changed from ₹ -0.06 crore to ₹ 0.15 crore over 9 quarters. This represents a CAGR of NaN% The net profit of Tarsons Products Ltd changed from ₹ 4.02 crore to ₹ -1.44 crore over 9 quarters. This represents a CAGR of NaN% The Dividend Payout of Fortis Malar Hospitals Ltd changed from 168.63 % on March 2024 to 0 % on March 2026 . This represents a CAGR of -100.00% over 3 yearsThe Dividend Payout of Tarsons Products Ltd changed from 20.76 % on March 2024 to 0 % on March 2026 . This represents a CAGR of -100.00% over 3 years .

About Fortis Malar Hospitals Ltd

Fortis Malar Hospital Limited, formerly known as Malar Hospital Limited was established on April 12, 1989 to set up, manage and operate a multi-specialty hospital.
Company is a subsidiary of Fortis Hospitals Limited and Fortis Healthcare Limited is the Intermediate Holding Company.
Later, the Company changed its name to 'Fortis Malar Hospital Limited' on December 21, 2010.
The Hospital building was owned by a fellow subsidiary, Fortis Health Management Limited (FHML) in early 2008. The hospital founded in 1989, has established itself as one of the largest corporate hospitals in Chennai, providing quality super specialty and multi-speciality healthcare services.
With a total bed-strength of 160, including 40 ICU/CCU/RTU beds, the hospital focuses on providing comprehensive medical care in the areas of Cardiology and Cardiac Surgery, Neuro Surgery, Gynaecology, Orthopedics, Gastroenterology, Neurology, Pediatrics, Diabetics, Nephrology and Internal Medicine All the above departments are fully became operational under phase I of the project.

About Tarsons Products Ltd

Tarsons Products Limited was incorporated as Tarsons Products Private Limited on July 5, 1983.
The Company was subsequently converted into a Public Limited Company and the name of the Company was changed to Tarsons Products Limited on June 14, 2021. Tarsons is an Indian labware Company engaged in designing, developing, manufacturing and marketing of consumables', reusables' and others' (including benchtop equipment), used in various laboratories across research organizations, academia institutes, pharmaceutical companies, CROs, diagnostic companies and hospitals.
The Company is also engaged in the manufacturing of wide range of quality labware products which helps scientific discovery and improve healthcare.
Tarsons currently operate through five manufacturing facilities located in West Bengal.

FAQs for the comparison of Fortis Malar Hospitals Ltd and Tarsons Products Ltd

Which company has a larger market capitalization, Fortis Malar Hospitals Ltd or Tarsons Products Ltd?

Market cap of Fortis Malar Hospitals Ltd is 75 Cr while Market cap of Tarsons Products Ltd is 1,595 Cr

What are the key factors driving the stock performance of Fortis Malar Hospitals Ltd and Tarsons Products Ltd?

The stock performance of Fortis Malar Hospitals Ltd and Tarsons Products Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Fortis Malar Hospitals Ltd and Tarsons Products Ltd?

As of October 25, 2026, the Fortis Malar Hospitals Ltd stock price is INR ₹40.21. On the other hand, Tarsons Products Ltd stock price is INR ₹299.95.

How do dividend payouts of Fortis Malar Hospitals Ltd and Tarsons Products Ltd compare?

To compare the dividend payouts of Fortis Malar Hospitals Ltd and Tarsons Products Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.